Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells
Keywords: سرطان های پستان منفی سه گانه; Triple negative breast cancers; PARP inhibitor; Histone deacetylase inhibitor; Homologous recombination; BRCA1 mutated cells;